Navigation Links
Adeona Reports Third Quarter 2011 Financial Results
Date:11/14/2011

a number of risks and uncertainties, many of which are difficult to predict and include statements regarding the expanded opportunities that exist for us, the planned commercial launch of wellZin, as well as the development of reaZin, our ability to obtain INDs in a timely manner for some of our drug candidates, the ability of our current cash position to meet our planned needs for the next 12 month, and the anticipated enrollment, timing or results of our planned Alzheimer's, ALS or multiple sclerosis cognition clinical trials. The forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from those reflected in Adeona's forward-looking statements include, among others, our failure to successfully commercialize wellZin for the common cold, develop reaZin as a medical food for the dietary management of zinc deficiency associated with Alzheimer's disease, develop AEN-100 as a treatment for Alzheimer's or ALS, or develop Trimesta as a treatment for relapses or cognitive dysfunction in multiple sclerosis, the failure of reaZin or wellZin to be accepted for either use, failure of future clinical trials of any of our drug candidates to be enrolled in and completed in the anticipated time or to achieve the desired results, the failure of Meda to commercialize flupirtine and to make any other payments under the sublicense agreement, and other factors described in Adeona's report on Form 10-K for the year ended December 31, 2010 and any other filings with the SEC. The information in this release is provided only as of the date of this release, and Adeona undertakes no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required
'/>"/>

SOURCE Adeona Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Adeona and the Skirball Foundation Join Forces to Advance Multiple Sclerosis Research
2. Adeona Senior Vice President of Research & Development to Present at American College of Nutrition Annual Meeting
3. Adeona Appoints Jeff Lucero Riley as Independent Chairman
4. Adeonas Planned Clinical Trial of Proprietary Zinc-Based Therapy in Lou Gehrigs Disease is Hot Topic at 2011 California ALS Research Summit
5. Adeona Announces Completion of Planned Enrollment in Phase II Multiple Sclerosis Clinical Trial
6. Adeona Appoints George A. Eby to Scientific Advisory Board
7. Adeona Reports Second Quarter 2011 Financial Results
8. Adeona to Host Second Quarter 2011 Investor Conference Call
9. Adeona Executes Agreement to Initiate Phase IIb Clinical Trial of Proprietary Zinc-Based Therapy in Lou Gehrigs Disease (ALS)
10. Adeona Reports 1st Quarter 2011 Financial Results
11. Adeona to Host First Quarter 2011 Investor Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... 2015  (MUSE Booth # 1510)What:Automating continuous vital ... is invaluable in any hospital setting, but particularly ... requirement and mainstream in healthcare, the integration of ... is gaining traction in MEDITECH facilities.During MUSE 2015 ... Project Manager & Clinical Analyst at McLaren Huron ...
(Date:5/21/2015)... , 21. Mai 2015 /PRNewswire/ ... DPRX ), ein Unternehmen für Arzneimittel ... die Entwicklung und Vermarktung von Locilex® ... kündigte heute eine wissenschaftliche Posterpräsentation an, ... des Unternehmens vorstellt, OneStep-1 und OneStep-2, ...
(Date:5/21/2015)... CHICAGO , May 21, 2015  Heidrick & ... executive search , leadership consulting and ... life sciences expertise among global practices announcing the addition ... Chicago office. Dietlin ... has worked globally and across R&D, Medical and Commercial ...
Breaking Medicine Technology:Hospital Streamlines ICU Efficiency with Timely Data Integration 2Hospital Streamlines ICU Efficiency with Timely Data Integration 3Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 2Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 3Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 4Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 5Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 6Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 7Heidrick Increases Healthcare and Life Sciences Expertise 2
... June 1 Shionogi Pharma, Inc., a U.S.-based group company ... two pivotal studies of the investigational new drug PSD502, a topical metered ...  These data were presented at the 2010 American Urological Association (AUA) Annual ... , , ...
... , June 1 OrthoDynamix announces a ... Biter is the first ever disposable biter used for ... every procedure affords the ultimate tissue interaction.  Moreover, the ... capsule structures.  Besides the jaw,s ability to bend 180 degrees, the ...
Cached Medicine Technology:Pivotal Data for the Investigational Treatment PSD502 for Primary Premature Ejaculation in the United States to be Presented at Major Medical Meeting 2Pivotal Data for the Investigational Treatment PSD502 for Primary Premature Ejaculation in the United States to be Presented at Major Medical Meeting 3Pivotal Data for the Investigational Treatment PSD502 for Primary Premature Ejaculation in the United States to be Presented at Major Medical Meeting 4
(Date:5/25/2015)... After the sensational buzz surrounding their past two ... Trivedi Master Wellness™ agrees to hold another ... “Consciousness is Power.” Presently, the Live-Streaming event is scheduled ... routinely allotted time from 10:00pm PST/1:00pm EST to 6:00pm ... to the public and accessible on the web through ...
(Date:5/24/2015)... The Rolling Stones Zip Code summer stadium ... Petco Park. This iconic group is ready for their ... had a warmup show in Los Angeles at the Henry ... this beloved band not only played their Sticky Fingers album ... "Jumping Jack Flash," "Moonlight Mile" and "All Down the ...
(Date:5/24/2015)... 24, 2015 EnviroLeather™ by LDI, ... Plus” – a classic, rugged leather grain with ... difficult stains, including ink, to be easily removed. ... suitable for corporate, healthcare, hospitality and education environments. ... EnviroLeather’s goal of developing products that are more ...
(Date:5/24/2015)... May 24, 2015 ... CEO - The students were ... at the fourth annual A Day ... at Geneva National in Lake Geneva. ...     -Badger High School,         Jonathan Alfonso,         Bridget ...
(Date:5/23/2015)... With the implementation of the Affordable ... increasingly difficult to provide their employees with a viable ... insurance for employees stand to face strict penalties. Never ... part of a business’s success or failure. In an ... USA Doctors has created a varying level of less ...
Breaking Medicine News(10 mins):Health News:Hundreds of People Are Thrilled to Hear that Trivedi Master Wellness™ Promises to Hold Another Workshop in June 2015 2Health News:Hundreds of People Are Thrilled to Hear that Trivedi Master Wellness™ Promises to Hold Another Workshop in June 2015 3Health News:The Rolling Stones Tickets in San Diego, Orlando, Minneapolis, Dallas, Pittsburgh, Indianapolis, Atlanta, Detroit, Milwaukee, Kansas City, Columbus, Nashville & Raleigh 2Health News:EnviroLeather By LDI Launches "InkGard Plus" - Stain Resistant Faux Leather 2Health News:Mercy Foundation Honors 16 Students for Making a Difference - Mercy Health System Javon Bea 2Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 2Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 3
... Pa., April 15 Law Offices of Howard ... Inverness Medical,Innovations, Inc. ("Inverness Medical" or the "Company") ... savings plan (the "Plan"),imprudently invested in Inverness Medical ... duties to the Plan,s participants,in violation of the ...
... president and chief financial officer also appointed, PLANO, ... and chief executive officer of LifeCare Holdings, Inc., a,20-facility ... Texas.,Chief Financial Officer Phillip B. Douglas has been promoted ... chief accounting officer,will now serve as CFO., McAlister ...
... study reports that inner-city children with asthma may ... below current air quality standards. The study, available ... pollution levels on asthma symptoms and lung function ... National Institutes of Health (NIH) and the Environmental ...
... As taxpayers scramble to file on,time, hundreds ... Illinois Governor and,Congressional delegation to make wiser ... pours into Illinois annually from federal tax,sources ... restrict educators from mentioning contraceptives,or condoms except ...
... oral drug could benefit many with the autoimmune disease, researchers ... pill designed to reduce the number of attacks in people ... Italian researchers report. , The pill was effective in preventing ... the pill for three years, according to research that was ...
... Than One Week Away, AARP Members,Gather On Wednesday ... Philadelphia., PHILADELPHIA, April 15 With a ... the nation will be,watching Sen. Barack Obama and ... Party,s presidential nomination during a debate Wednesday,night in ...
Cached Medicine News:Health News:LifeCare Holdings, Inc. Names McAlister Chairman and CEO 2Health News:Air pollution affects respiratory health in children with asthma 2Health News:Youth and Adults Throughout Illinois Urge Governor Blagojevich and Congress: Invest Our Tax Dollars Wisely 2Health News:Youth and Adults Throughout Illinois Urge Governor Blagojevich and Congress: Invest Our Tax Dollars Wisely 3Health News:Pill Reduces Relapses in MS Patients 2Health News:AARP to Host Discussion and Debate Watch Event 2Health News:AARP to Host Discussion and Debate Watch Event 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: